Risk of Osteoporotic Fractures with Use of Cyclooxygenase-2 Inhibitors

Oct-15

AUTHORS : Dr Deepan Dalal (Details for study: Boston Medical Center), Division of Rheumatology, Brown University School of Medicine, Brown University Warren Alpert School of Medicine, 375 Wampanoag Trail, Office 289, E. Providence, RI, 02915, USA (Division of Rheumatology, Brown Physicians Patient Center, 375 Wampanoag Trail, Suite 402, East Providence, RI 02915; on profile) – Email: deepan_dalal@brown.edu / deepan.dalal@lifespan.org – Profile: http://www.brownmed.org/provider-info/?ID=1350

JOURNAL : Arthritis & Rheumatology

REFERENCE: 67(S10)

DOI : 10.1002/art.39448

Risk of Osteoporotic Fractures with Use of Cyclooxygenase-2 Inhibitors

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study